We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$26.6B
AUM Growth
+$2.81B
Cap. Flow
+$487M
Cap. Flow %
1.83%
Top 10 Hldgs %
39.26%
Holding
604
New
63
Increased
202
Reduced
200
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 26.69%
2 Healthcare 22.4%
3 Consumer Discretionary 15.48%
4 Communication Services 9.79%
5 Financials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
326
NextEra Energy
NEE
$185B
$923K ﹤0.01%
22,040
+148
+0.7% +$6.3K
MMSI icon
327
Merit Medical Systems
MMSI
$4.54B
$922K ﹤0.01%
+15,000
New +$862K
VLO icon
328
Valero Energy
VLO
$90.5B
$921K ﹤0.01%
8,093
+55
+0.7% +$6.25K
EC icon
329
Ecopetrol
EC
$32.5B
$912K ﹤0.01%
33,871
+1,771
+6% +$39.2K
DRI icon
330
Darden Restaurants
DRI
$23.4B
$880K ﹤0.01%
7,912
-2,457
-24% -$277K
MA icon
331
Mastercard
MA
$487B
$872K ﹤0.01%
3,918
+17
+0.4% +$3.55K
SGMO
332
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$864K ﹤0.01%
51,000
+11,000
+28% +$167K
TLRY icon
333
Tilray
TLRY
$498M
$855K ﹤0.01%
+595
New +$382K
KSS icon
334
Kohl's
KSS
$2.1B
$850K ﹤0.01%
+11,398
New +$862K
GBT
335
DELISTED
Global Blood Therapeutics, Inc.
GBT
$836K ﹤0.01%
22,000
-9,788
-31% -$434K
ARGX icon
336
argenx
ARGX
$55.6B
$834K ﹤0.01%
11,000
+8,000
+267% +$709K
CX icon
337
Cemex
CX
$17.6B
$804K ﹤0.01%
114,221
-7,800
-6% -$54.7K
TTOO
338
DELISTED
T2 Biosystems, Inc
TTOO
$797K ﹤0.01%
21
NBIS
339
Nebius Group N.V.
NBIS
$47.7B
$782K ﹤0.01%
23,790
-6,675
-22% -$226K
RVNC
340
DELISTED
Revance Therapeutics, Inc.
RVNC
$746K ﹤0.01%
30,000
KHC icon
341
Kraft Heinz
KHC
$31.1B
$744K ﹤0.01%
13,509
WDC icon
342
Western Digital
WDC
$172B
$725K ﹤0.01%
16,380
-29
-0.2% -$1.47K
TTEK icon
343
Tetra Tech
TTEK
$8.28B
$668K ﹤0.01%
48,905
ACN icon
344
Accenture
ACN
$94.3B
$649K ﹤0.01%
3,816
-180
-5% -$30K
BPMC
345
DELISTED
Blueprint Medicines
BPMC
$624K ﹤0.01%
8,000
-500
-6% -$34.8K
BRFS
346
DELISTED
BRF SA
BRFS
$619K ﹤0.01%
+113,000
New +$628K
NKE icon
347
Nike
NKE
$62.5B
$617K ﹤0.01%
7,286
+155
+2% +$12.4K
VKTX icon
348
Viking Therapeutics
VKTX
$4.05B
$610K ﹤0.01%
+35,000
New +$417K
MMM icon
349
3M
MMM
$91.9B
$582K ﹤0.01%
3,306
PUMP icon
350
ProPetro Holding
PUMP
$1.32B
$571K ﹤0.01%
34,600
-33,910
-49% -$547K

Similar funds

Fred Alger Management's Q3 2018 Portfolio in Review

As of Q3 2018, Fred Alger Management held 604 positions worth $26.6B, up 12% from $23.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fred Alger Management's Q3 2018 filing shows 63 new, 202 increased, 200 reduced and 70 closed positions. Its largest new stake was lululemon athletica: 790,453 shares worth $128M. The largest sale was Broadcom, an estimated $245M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fred Alger Management's largest Q3 2018 buy was lululemon athletica: 790,453 shares worth $128M.
  • Fred Alger Management added most to Thermo Fisher Scientific in Q3 2018, an estimated $213M increase.
  • Fred Alger Management's biggest Q3 2018 reduction was Broadcom, cutting an estimated $245M.
  • Fred Alger Management fully exited Halliburton in Q3 2018, selling an estimated $32.1M.
  • Fred Alger Management's ten largest holdings make up 39% of its $26.6B portfolio in Q3 2018.
  • Fred Alger Management opened 63 new positions and closed 70 in Q3 2018.
  • Fred Alger Management's portfolio value rose 12% quarter-over-quarter to $26.6B.

Based on Fred Alger Management's 13F filing for Q3 2018, filed 14 Nov 2018.